For the third quarter of 2025, as compared to the same period one year prior, Exponent (EXPO) anticipates: Revenues before reimbursements to be up in the mid-single digits; and, EBITDA1 to be 26.75% to 27.75% of revenues before reimbursements.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO: